Lsmini Strawberry Syrup is a combination pharmaceutical formulation containing Levosalbutamol (0.5mg/5ml), Ambroxol (15mg/5ml), and Guaifenesin (50mg/5ml), designed to provide symptomatic relief in respiratory conditions characterized by bronchospasm, mucus hypersecretion, and productive cough. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby improving airflow and reducing bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). Ambroxol serves as a mucolytic agent that facilitates the breakdown and clearance of viscous mucus by stimulating the production of serous mucus and enhancing ciliary motility, which aids in expectoration. Guaifenesin functions as an expectorant, promoting the thinning and loosening of mucus in the respiratory tract to ease cough and improve mucus clearance. The syrup’s strawberry flavor enhances palatability, making it suitable for pediatric and adult patients requiring combination therapy for acute or chronic respiratory conditions involving bronchoconstriction and mucus retention. Lsmini Strawberry Syrup should be used under medical supervision, with dosage adjusted according to patient age and clinical response, and is contraindicated in individuals with hypersensitivity to any of its components.